RxDoctor Payments DataLook up a doctor →

Rajaprabhakaran Rajarethinam, MD

Psychiatry · Ann Arbor, MINPI 1427095918

Payments from drug & device makers

$1,177,983in general payments, 2019–2025

Across 424 payments — averaging $2778.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Livanova USA, Inc.$299K
  • E.r. Squibb & Sons, L.L.C.$147K
  • Boehringer Ingelheim$123K
  • Neurocrine Biosciences, Inc.$118K
  • Biohaven Pharmaceutical Holding Company Ltd.$112K
  • F. Hoffmann-la Roche AG$94K
  • plus $286K from 12 others

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,177,983 in reported general payments places this provider in the 95th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$4,206
Medicare patients
12
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →